C. Lohmann

Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

Hayley S. Brown, J. Houston, D. Hallifax, 2007, Drug metabolism reviews.

Scintillation proximity assay for measuring uptake by the human drug transporters hOCT1, hOAT3, and hOATP1B1.

L. Gustavsson, C. Lohmann, J. Hoogstraate, 2007, Analytical biochemistry.

TIMP-3: a novel target for glucocorticoid signaling at the blood-brain barrier.

H. Galla, C. Lohmann, Patrick Zeni, 2009, Biochemical and Biophysical Research Communications - BBRC.

Sodium‐dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L‐ascorbic acid into Schwann cells

H. Halfter, C. Lohmann, B. Gess, 2009, Glia.

Tyrosine phosphatase inhibition induces loss of blood–brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways

H. Galla, J. Wegener, C. Lohmann, 2004, Brain Research.

Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays

C. Lohmann, S. Hüwel, H J Galla, 2002, Journal of drug targeting.

In vitro studies indicate that miquelianin (quercetin 3-O-beta-D-glucuronopyranoside) is able to reach the CNS from the small intestine.

H. Galla, A. Nahrstedt, C. Lohmann, 2003, Planta medica.

Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2.

L. Gustavsson, C. Lohmann, A. Blomgren, 2013, Journal of medicinal chemistry.